Noor MA - Search Results

1

Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity: demonstrable differences in vitro and clinically.

Noor MA, Flint OP, Maa JF, Parker RA. Noor MA, et al. AIDS. 2006 Sep 11;20(14):1813-21. doi: 10.1097/01.aids.0000244200.11006.55. AIDS. 2006. PMID: 16954722 Clinical Trial.

2

The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.

Noor MA, Parker RA, O'Mara E, Grasela DM, Currie A, Hodder SL, Fiedorek FT, Haas DW. Noor MA, et al. AIDS. 2004 Nov 5;18(16):2137-44. doi: 10.1097/00002030-200411050-00005. AIDS. 2004. PMID: 15577646 Clinical Trial.

3

The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications.

Flint OP, Noor MA, Hruz PW, Hylemon PB, Yarasheski K, Kotler DP, Parker RA, Bellamine A. Flint OP, et al. Among authors: noor ma. Toxicol Pathol. 2009 Jan;37(1):65-77. doi: 10.1177/0192623308327119. Epub 2009 Jan 26. Toxicol Pathol. 2009. PMID: 19171928 Free PMC article. Review.

4

Genetic analysis implicates resistin in HIV lipodystrophy.

Ranade K, Geese WJ, Noor M, Flint O, Tebas P, Mulligan K, Powderly W, Grinspoon SK, Dube MP. Ranade K, et al. AIDS. 2008 Aug 20;22(13):1561-8. doi: 10.1097/QAD.0b013e32830a9886. AIDS. 2008. PMID: 18670214 Free PMC article.

5

Endoplasmic reticulum stress links dyslipidemia to inhibition of proteasome activity and glucose transport by HIV protease inhibitors.

Parker RA, Flint OP, Mulvey R, Elosua C, Wang F, Fenderson W, Wang S, Yang WP, Noor MA. Parker RA, et al. Among authors: noor ma. Mol Pharmacol. 2005 Jun;67(6):1909-19. doi: 10.1124/mol.104.010165. Epub 2005 Mar 8. Mol Pharmacol. 2005. PMID: 15755908

6

The metabolic effects of lopinavir/ritonavir in HIV-negative men.

Lee GA, Seneviratne T, Noor MA, Lo JC, Schwarz JM, Aweeka FT, Mulligan K, Schambelan M, Grunfeld C. Lee GA, et al. Among authors: noor ma. AIDS. 2004 Mar 5;18(4):641-9. doi: 10.1097/00002030-200403050-00008. AIDS. 2004. PMID: 15090769 Free PMC article.

7

The role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: cellular mechanisms and clinical implications.

Noor MA. Noor MA. Curr HIV/AIDS Rep. 2007 Aug;4(3):126-34. doi: 10.1007/s11904-007-0019-4. Curr HIV/AIDS Rep. 2007. PMID: 17883998 Review.

8

Indinavir increases glucose production in healthy HIV-negative men.

Schwarz JM, Lee GA, Park S, Noor MA, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M, Grunfeld C. Schwarz JM, et al. Among authors: noor ma. AIDS. 2004 Sep 3;18(13):1852-4. doi: 10.1097/00002030-200409030-00017. AIDS. 2004. PMID: 15316349

9

Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study.

Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Mulligan K, Schambelan M, Grunfeld C. Noor MA, et al. AIDS. 2002 Mar 29;16(5):F1-8. doi: 10.1097/00002030-200203290-00002. AIDS. 2002. PMID: 11964551 Free PMC article. Clinical Trial.

10

Metabolic effects of indinavir in healthy HIV-seronegative men.

Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C. Noor MA, et al. AIDS. 2001 May 4;15(7):F11-8. doi: 10.1097/00002030-200105040-00001. AIDS. 2001. PMID: 11399973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters